Vaccines for Children (VFC) FY26
Award Notice Posted
- Solicitation number
- 75D30126R73375
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- to Glaxosmithkline, LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D30126D20728 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Georgia 30341, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) Office of Acquisition Services has awarded contract 75D30126D20728 to GlaxoSmithKline, LLC on March 27, 2026, for the Vaccines for Children (VFC) program in fiscal year 2026. The contract is valued at approximately $1.465 billion and pertains to the procurement of vaccines for the federally funded VFC program, which provides immunizations to eligible children. This award notice indicates a significant investment in pediatric vaccination services, with no set-aside restrictions applied to this opportunity. The contract award demonstrates the government's commitment to maintaining a robust supply of vaccines for the VFC program during the fiscal year.
Notice text
Awarded contract 75D30126D20728 to GLAXOSMITHKLINE, LLC for 1465091900.00 on 2026-03-27.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Vaccines for Children (VFC) FY26 | Award Notice | |
| Vaccines for Children (VFC) FY26 | Award Notice | |
| Vaccines for Children (VFC) FY26 | Award Notice | |
| This notice | Award Notice |
4 of 5 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity